Silver Brian M. 4
4 · TScan Therapeutics, Inc. · Filed Jul 16, 2021
Insider Transaction Report
Form 4
Silver Brian M.
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2021-07-15+250,441→ 250,441 totalExercise: $15.00Exp: 2031-07-14→ Voting Common Stock (250,441 underlying)
Footnotes (1)
- [F1]The shares subject to this option will vest with respect to 25% of the shares after 12 months of continuous service to the Issuer following May 3, 2021, and the balance will vest in equal monthly installments over the next 36 months of continuous service to the issuer. If Mr. Silver's employment is terminated without cause or for good reason within the three months prior to a change of control or within 12 months at or following a change of control, any unvested shares or equity awards shall immediately vest.